Cargando…

In Vitro Synergy of Cefamandole-Tobramycin Combinations

Twenty-five isolates of Staphylococcus aureus, 24 isolates of Escherichia coli, and 25 isolates of Klebsiella pneumoniae obtained from clinical material were tested in vitro for susceptibility to cefamandole, tobramycin and combinations of the two antibiotics utilizing an automated microdilution sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valenti, August J., Siniscalchi, Alan J., Andriole, Vincent T.
Formato:	Texto
Lenguaje:	English
Publicado:	1977
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2595402/ https://www.ncbi.nlm.nih.gov/pubmed/331694

Ejemplares similares

In Vitro Susceptibility of Selected Bacteria to Cefaclor
por: Valenti, August J., et al.
Publicado: (1977)

Synergy of Vancomycin with Penicillins and Cephalosporins Against Pseudomonas, Klebsiella, and Serratia
por: Donabedian, Haig, et al.
Publicado: (1977)

Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.
por: Downs, J. T., et al.
Publicado: (1986)

Meta-Analysis of Clinical Trials Comparing Cefazolin to Cefuroxime, Ceftriaxone, and Cefamandole for Surgical Site Infection Prevention
por: Ahmed, Nehad J., et al.
Publicado: (2022)

Treatment of Gram-Negative Bacillary Meningitis With Intrathecal Gentamicin
por: Mangi, Richard J., et al.
Publicado: (1977)

Transient Bacteremia Due to Suction Abortion: Implications for SBE Antibiotic Prophylaxis
por: Ritvo, Rachel, et al.
Publicado: (1977)

Neutropenia during High Dose Intravenous Oxacillin Therapy
por: Ahern, Mary Jean, et al.
Publicado: (1976)

The ineffectiveness of tobramycin combination therapy in Streptococcus faecium endocarditis.
por: Goldstein, J. A., et al.
Publicado: (1983)

Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa
por: Okoliegbe, Ijeoma N., et al.
Publicado: (2021)

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model
por: Tait, Jessica R., et al.
Publicado: (2022)

703. Mechanisms of High-Level Ceftolozane/Tazobactam (CT) Resistance Against Pseudomonas aeruginosa and Synergy Between CT and Tobramycin (TOB)
por: So, Wonhee, et al.
Publicado: (2018)

Combinations
por: Chandler, J. B.
Publicado: (1882)

Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation
por: Gauthier, Timothy P., et al.
Publicado: (2015)

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
por: MacLeod, David L., et al.
Publicado: (2009)

Tobramycin and vestibulotoxicity: retrospective analysis of four cases
por: Vonk, S E M, et al.
Publicado: (2022)

Tobramycin Nanoantibiotics and Their Advantages: A Minireview
por: Rosalia, Mariella, et al.
Publicado: (2022)

Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis
por: Deschamp, Ashley R, et al.
Publicado: (2017)

Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections
por: Ham, So-Young, et al.
Publicado: (2021)

Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa
por: Jin, Li-Min, et al.
Publicado: (2023)

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii
por: Alarfaj, Reem E., et al.
Publicado: (2022)

Determination of Tobramycin and Vancomycin Exposure Required to Eradicate Biofilms on Muscle and Bone Tissue In Vitro
por: Badha, Vajra, et al.
Publicado: (2019)

Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Coulter, Lindsey B., et al.
Publicado: (2014)

Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients
por: Ting, L, et al.
Publicado: (2014)

Efficacy of inhaled tobramycin in severe nosocomial pneumonia
por: Kuzovlev, A, et al.
Publicado: (2012)

Inhaled tobramycin for the treatment of nosocomial pneumonia in sepsis
por: Kuzovlev, A, et al.
Publicado: (2014)

Impact of tobramycin on the performance of microbial fuel cell
por: Wu, Wenguo, et al.
Publicado: (2014)

Development of a novel tobramycin dependent riboswitch
por: Kraus, Leon, et al.
Publicado: (2023)

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
por: Greenwood, James, et al.
Publicado: (2017)

Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing
por: Chanda, Warren, et al.
Publicado: (2017)

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2023)

In vitro synergy of isavuconazole in combination with colistin against Candida auris
por: Schwarz, Patrick, et al.
Publicado: (2020)

2809. In Vitro Synergy of Antibiotic Combinations Against Enterococcus gallinarum
por: Landman, David, et al.
Publicado: (2023)

An in vitro screening cascade to identify neuroprotective antioxidants in ALS
por: Barber, Siân C., et al.
Publicado: (2009)

Role of Tobramycin in the Induction and Maintenance of Viable but Non-Culturable Pseudomonas aeruginosa in an In Vitro Biofilm Model
por: Mangiaterra, Gianmarco, et al.
Publicado: (2020)

Assessing tobramycin levels and renal function following the implantation of CaSO(4) beads impregnated with tobramycin: A prospective cohort study
por: Alowais, Shuroug A., et al.
Publicado: (2022)

Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
por: Longenecker, Ryan J., et al.
Publicado: (2021)

Does Addition of Tobramycin Powder Reduce Infection Rates After Spine Surgery?
por: Lee, Yu-Po, et al.
Publicado: (2018)

Formulation and characterization of tobramycin-chitosan nanoparticles coated with zinc oxide nanoparticles
por: Al-nemrawi, Nusaiba.K., et al.
Publicado: (2022)

Association of Plasmodium falciparum with Human Endothelial Cells in vitro
por: Utter, Christopher, et al.
Publicado: (2017)

Adherence with tobramycin inhaled solution and health care utilization
por: Briesacher, Becky A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8jj98e972pkn8qhgln6i0i30gq